Ptc Therapeutics, Inc. · NASDAQ:PTCT

Boulding Mark Elliott sold 2,813 Ptc Therapeutics, Inc. shares (Form 4)

Traded Aug 17, 2026 · Filed Aug 19, 2026

On Aug 17, 2026, Boulding Mark Elliott (EXEC. VP AND CLO) sold 2,813 Ptc Therapeutics, Inc. shares at an average US$72.57 for US$204K under a trading plan, leaving 105,272 shares. Filed Aug 19, 2026 (Form 4).

Sold
2,813 shares
Price
US$72.57 average (US$72.39 to US$72.90)
Value
US$204K
Holding after
105,272 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EXEC. VP AND CLO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 17, 2026Common StockOption exercise2,813US$25.69108,085Direct
Aug 17, 2026Common StockSale1,844US$72.39106,241Direct
Aug 17, 2026Common StockSale969US$72.90105,272Direct

Source

View original at SEC

Related